(Q37839795)

24 August 2017

0 references

The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature (English)

1 reference

24 August 2017

1 reference

Shu Zhao

1

1 reference

24 August 2017

Yupeng Liu

2

1 reference

24 August 2017

Qingyuan Zhang

3

1 reference

24 August 2017

Hongbin Li

4

1 reference

24 August 2017

Minghui Zhang

5

1 reference

24 August 2017

Wenjie Ma

6

1 reference

24 August 2017

Wenhui Zhao

7

1 reference

24 August 2017

Jingxuan Wang

8

1 reference

24 August 2017

Maopeng Yang

9

1 reference

24 August 2017

language of work or name

English

0 references

publication date

11 February 2011

1 reference

Breast Cancer Research and Treatment

24 August 2017

published in

1 reference

24 August 2017

volume

130

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

809-816

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1379-4

24 August 2017

exact match

0 references

cites work

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Chemokines in neoplastic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1379-4

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

21 January 2018

Cancer statistics, 2009

1 reference

28 May 2022

Identifiers

DOI

10.1007/S10549-011-1379-4

1 reference

24 August 2017

1 reference